Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes
- PMID: 20367890
- DOI: 10.1017/S1041610210000281
Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes
Abstract
Background: Neuropsychiatric disorders are common in cognitively impaired older persons, and associated with institutionalization and caregiver stress in Alzheimer's disease (AD). Few studies have compared the occurrence of both psychiatric disorders and neuropsychiatric symptoms in patients with AD and mild cognitive impairment (MCI) subtypes. We aimed to investigate the frequency of psychiatric disorders and neuropsychiatric symptoms in AD and MCI patients, compared to controls.
Methods: We included 245 outpatients of a memory clinic in Rome, Italy (119 AD; 68 multidomain-MCI; 58 amnestic-MCI) and 107 controls. Categorical disorders of depression and apathy were diagnosed with structured interviews. Symptoms were evaluated with the Neuropsychiatric Inventory (NPI). The odds ratios (OR) of patients having neuropsychiatric symptoms compared to controls were calculated with logistic regression, adjusted for sociodemographic and clinical variables.
Results: A large proportion of AD (49.6%) and multidomain-MCI (44.1%) patients had depression disorder. Apathy disorder was common in AD (51.3%) but less frequent in amnestic-MCI (6.9%) and multidomain-MCI (14.7%). AD patients were three times more likely to have depression disorders (OR = 3.0, CI = 1.1-7.6) or apathy (OR = 16.9, CI = 4.6-61.8) compared to amnestic-MCI, and seven times more likely to have apathy disorder than multidomain-MCI (OR = 7.5, CI = 3.0-19.2). After apathy and depression, the most prevalent neuropsychiatric symptoms in AD and MCI were anxiety, agitation, irritability, night-time behaviors, and appetite disturbances. There was an increasing prevalence of many neuropsychiatric symptoms with increasing severity of cognitive syndromes.
Conclusions: Clinicians should consider the relevance of neuropsychiatric disorders and symptoms in patients with cognitive disturbances, and incorporate a thorough psychiatric examination in the evaluation of patients.
Similar articles
-
Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy.J Alzheimers Dis. 2010;20(1):175-83. doi: 10.3233/JAD-2010-1352. J Alzheimers Dis. 2010. PMID: 20164594
-
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.Curr Alzheimer Res. 2010 Sep;7(6):517-26. doi: 10.2174/156720510792231748. Curr Alzheimer Res. 2010. PMID: 20455862
-
Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms.Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):17-21. doi: 10.1097/00002093-200401000-00004. Alzheimer Dis Assoc Disord. 2004. PMID: 15195459
-
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.Dement Geriatr Cogn Disord. 2007;24(6):457-63. doi: 10.1159/000110738. Epub 2007 Nov 7. Dement Geriatr Cogn Disord. 2007. PMID: 17986816 Review.
-
Common Neuropsychiatric S ymptoms in Alzheimer's Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework.Curr Alzheimer Res. 2023;20(7):459-470. doi: 10.2174/0115672050255489231012072014. Curr Alzheimer Res. 2023. PMID: 37873914 Review.
Cited by
-
Sleep Disturbance in Mild Cognitive Impairment and Association With Cognitive Functioning. A Case-Control Study.Front Aging Neurosci. 2018 Nov 9;10:360. doi: 10.3389/fnagi.2018.00360. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30473661 Free PMC article.
-
Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment.Front Aging Neurosci. 2021 Dec 8;13:718949. doi: 10.3389/fnagi.2021.718949. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34955804 Free PMC article.
-
Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.J Neural Transm (Vienna). 2018 Jan;125(1):53-66. doi: 10.1007/s00702-017-1709-8. Epub 2017 Mar 14. J Neural Transm (Vienna). 2018. PMID: 28293733 Review.
-
Neuropsychiatric symptoms in mild cognitive impairment: An analysis and its impact on caregiving.Indian J Psychiatry. 2013 Apr;55(2):154-60. doi: 10.4103/0019-5545.111454. Indian J Psychiatry. 2013. PMID: 23825850 Free PMC article.
-
Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.J Alzheimers Dis. 2013;35(2):363-71. doi: 10.3233/JAD-122359. J Alzheimers Dis. 2013. PMID: 23403534 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical